Home >> Report Store >> Healthcare >> Hormone Replacement Therapy (HRT) Market, By Replacement Therapy >

Hormone Replacement Therapy (HRT) Market Size Worth $30.4 Billion By 2025 | CAGR: 7.5%

Published Date : 15 / 05 / 18 | Report Format: PDF

The global Hormone Replacement Therapy (HRT) market is expected to grow at growth rate of 7.5% to reach USD 30.4 billion by 2025.

Menopause is a natural inevitable event, defined as the final menstrual period. It requires a retrospective clinical diagnosis with ethnic and regional variations. Hormonal replacement therapies (HRT) play an important role in relieving the symptoms of perimenopause and menopause. This therapy can be categorized into Oestrogen-alone HRT, cyclical HRT, continuous combined therapy (CCT), and long cycle HRT. It can be given transdermally (through the skin), orally (tablets), vaginally or subcutaneously (a long-lasting implant). Combination or in a systematic form which includes the application of drugs through patches, gels, and pills are considered to be the most preferred option of hormone therapy. The rise in a number of women in menopausal age, growing patient awareness, and the emergence of innovative drug delivery systems are driving the industry growth significantly. According to the statistics provided by the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause on a daily basis. This number is equivalent to about two million women annually in the U.S. alone.

However, availability of alternative treatment options would, in turn, hamper the market growth to some extent. For instance, antidepressants, antiseizure and blood pressure medications are sometimes used for the relief of menopausal symptoms. The high cost of products is also considered to be one of the major restraining factors for the market growth. For example, Pfizer, Inc. increased the price of its anticonvulsant Dilantin, hormone therapy Menest by around 20%.

Key Takeaways

  • Estrogen replacement therapy recorded USD 9.58 billion and is expected to soar owing to the approval of new products by the U.S. FDA
  • Thyroid replacement therapy is likely to be the lowest revenue generating segment and is also expected to register slowest growth rate in terms of value
  • Parenteral route of administration recorded the highest share of the global market owing to its associated benefits
  • Of the diseased segment, hypothyroidism is considered to be the lowest revenue generating segment
  • North America accounted the highest share, 41.67% of the total market owing to the rising hormonal disorders
  • Companies such as Amgen, Inc., Novo Nordisk, Eli Lily, Abbott, and Genentech are profiled. These key companies are enduring various mergers and acquisitions to expand their presence by reaching untapped areas in and outside the country.
  • The industry experience a high level of competition. In such fragmented landscape, key companies are collaborating with small scale or large scale player to expand their product offering and market presence.

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the key market dynamics
  • Granular analysis of the current market scenario and expected factors to affect the market
  • Detailed analysis of the geographic region, regional and county wise analysis
  • Highlight on the strategies that are being adopted by the key players in this market to stay competitive
  • Extensive analysis of the key players dominating the market

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation

MARKET, BY REPLACEMENT THERAPY

  • Estrogen
  • Human Growth Hormone
  • Testosterone
  • Thyroid

MARKET, BY ROUTE OF ADMINISTRATION

  • Parenteral
  • Oral
  • Transdermal
  • Other

MARKET, BY DISEASE

  • Male Hypogonadism
  • Menopause
  • Hypothyroidism
  • Growth Hormone Deficiency
  • Others

MARKET, BY REGION

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Why AnalystView?

Z

Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.

Y

Tailor-Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.

T

Data Accuracy and Reliability

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials

Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us

We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This